Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy
Tóm tắt
The impact of splenectomy on health-related quality of life (HRQoL) in patients with immune thrombocytopenia (ITP) remains scarcely explored. Therefore, we evaluated HRQoL with the 36-Item Short-Form Health Survey (SF-36) in an internal cohort of 69 chronic ITP patients, overall and by type of treatment. Of these patients, 26 patients were splenectomized, while other patients were treated medically with thrombopoietin-receptor agonists (TPO-RAs) or immunosuppressive treatment. We also compared HRQoL of the splenectomized patients (internal cohort) with an external cohort of 63 splenectomized ITP patients and the general population. The median follow-up was 10 years (range 1–20). Splenectomized patients had a worse overall HRQoL profile than those who received medical therapy either with TPO-RAs or other treatments (OT), with clinically meaningful differences registered in several domains. These included physical functioning (Δ = − 17.0 and Δ = − 15.2, for TPO-Ras and OT, respectively, p = 0.065), role physical (Δ = − 9.7 and Δ = − 13.8, p = 0.483), and bodily pain (Δ = − 14.2 and Δ = − 18.8, p = 0.053). Compared to the general population, both internal and external splenectomized cohorts had an impaired HRQoL profile. Further studies on HRQoL in splenectomized ITP patients are needed to better understand the long-term impact of this surgical procedure.
Tài liệu tham khảo
Cooper N, Ghanima W (2019) Immune thrombocytopenia. N Engl J Med 381(10):945–955
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3(22):3780–3817
Chaturvedi S, Arnold DM, McCrae KR 2018 Splenectomy for immune thrombocytopenia: down but not out. Blood 15;131(11):1172–82.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207
Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F et al (2016) Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol 91(10):995–1001
Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D et al (2021) Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): impact of ITP on health-related quality of life. Am J Hematol 96(2):199–207
Hill QA, Newland AC (2015) Fatigue in immune thrombocytopenia. Br J Haematol 170(2):141–149
Trotter P, Hill QA (2018) Immune thrombocytopenia: improving quality of life and patient outcomes. Patient Relat Outcome Meas. 9:369–384
Lebioda A, Batscheider A (2015) Health-related quality of life (Hrqol) In splenectomized immune thrombocytopenia (ITP) patients – a targeted literature review. Value Health. 1(18):A676
Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J (2008) Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin 24(10):2767–2776
George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R et al (2009) Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol 144(3):409–415
Suvajdzic N, Zivkovic R, Djunic I, Vidovic A, Markovic O, Marisavljevic D et al (2014) Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia. Platelets 25(6):467–469
Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PHB, George JN et al (2011) Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 86(5):420–429
Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51(11):1025–1036
Sloan J, Symonds T, Vargas-Chanes D, Fridley B (2003) Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Inf J 37(1):23–31
Colangelo KJ, Pope JE, Peschken C (2009) The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36. J Rheumatol 36(10):2231–2237
Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL (2007) A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther 29(5):950–962
Rodeghiero F (2018) A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol 181(2):183–195